Synthesis and Evaluation of (4-Chlorobenzhydryl) Piperazine Amides as Sodium Channel Nav1.7 Inhibitors
- Authors
- Back, Seung Keun; Kam, Yoo Lim; Oh, Jung Ae; Na, Heung Sik; Ih, Uhtaek; Choo, Hea-Young Park
- Issue Date
- 9월-2015
- Publisher
- WILEY-V C H VERLAG GMBH
- Keywords
- Nav1.7; Voltage Ion Probe Reader assay; Formalin test; Neuropathic pain
- Citation
- BULLETIN OF THE KOREAN CHEMICAL SOCIETY, v.36, no.9, pp.2290 - 2297
- Indexed
- SCIE
SCOPUS
KCI
- Journal Title
- BULLETIN OF THE KOREAN CHEMICAL SOCIETY
- Volume
- 36
- Number
- 9
- Start Page
- 2290
- End Page
- 2297
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/92592
- DOI
- 10.1002/bkcs.10446
- ISSN
- 0253-2964
- Abstract
- Blockage of voltage-gated sodium channels is used to treat neuropathic pain which is chronic and can become debilitating. Sodium channels Nav1.7-1.9 are especially attractive targets for drug discovery because of the broad therapeutic potential of their modulation. For a neuropathic pain therapy, anticonvulsant like lamotrigine, carbamazepine and a topical anesthetic such as Lidocaine are used. A growing number of clinical reports suggest that selective inhibitors of Nav1.7 are likely to be the powerful analgesics for treating a broad range of pain conditions. Therefore we evaluated 108 amide derivatives synthesized on human Nav1.7 (hNav1.7) by VIPR (voltage/ion probe reader), a fluorescence image plate reader (FLIPR) assay that used voltage-sensor fluorescence dye and stable HEK-293 cell lines expressing hNaV1.7. Ten compounds demonstrated inhibitory activity, and the two most active compounds (5 and 6) had IC50 values of 8-10 mu M.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medical Science > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.